Alpha Teknova Inc (TKNO)
Alpha Teknova Inc. is a healthcare company focused on making reagents and related laboratory materials used in research, development, and production workflows for novel therapies, vaccines, and molecular diagnostics. Its product set includes prepared media plates for cell growth and cloning, microbial culture media and supplements for cell expansion, and reagents used in sample processing, resuspension, and purification. The company also provides laboratory essentials for biological research and drug discovery, along with custom clinical solutions used in the development and manufacturing of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. Alpha Teknova serves pharmaceutical and biotechnology customers, contract development and manufacturing organizations, in vitro diagnostic companies, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TKNO
|
$3.86
|
-24.7% Downside
|
Overvalued
|
$9
|
75.6% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
-16.2x
|
4.3x
|
6.7x
|
284.2 M
|
288.3 M
|
8.9%
|
20.3%
|
3.0
|
—
|
52.8%
|
